Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions

Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions

10.1007/s12072-010-9163-9

Saved in:
Bibliographic Details
Main Authors: Ahn, S.H., Chan, H.L.Y., Chen, P.-J., Cheng, J., Goenka, M.K., Hou, J., Lim, S.G., Omata, M., Piratvisuth, T., Xie, Q., Yim, H.J., Yuen, M.-F.
Other Authors: MEDICINE
Format: Review
Published: 2011
Subjects:
ALT
Chronic hepatitis B (CHB)
HBV DNA
Hepatitis B virus (HBV)
Interferon alfa
Nucleoside/nucleotide analog
Online Access:http://scholarbank.nus.edu.sg/handle/10635/26950
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/26950

Similar Items